发明名称 Pharmaceutical Formulation
摘要 A pharmaceutical composition in the form of a tablet including a first portion and a second portion, wherein the first portion includes guaifenesin having an immediate release profile and a second drug having a sustained release profile, and wherein the second portion includes guaifenesin having a sustained release profile. The second drug can be in the form of a drug-resin complex. The second drug can be either an anti-tussive or a decongestant. The drug-resin complex includes a drug complexed to an ion exchange resin. The ion exchange resin can be a polystyrene sulfonate resin, polacrilex resin, polacrilin potassium, cholestyramine resin, or a colestyramine resin. The drug-resin complex can be provided with a coating, the coating thickness being selected to obtain the desired release profile. The drug-resin complex can be provided with a coating level of from 5% to 50%. The coating level can be from 10% to 35%.
申请公布号 US2016228386(A1) 申请公布日期 2016.08.11
申请号 US201615133062 申请日期 2016.04.19
申请人 Reckitt Benckiser LLC 发明人 Ahlgren Nils;Nuttall Mark;Wong Jeannie;Balasubramanian Venkatesh;Belongie Craig;Khan Ashfaq;Muir Neil Campbell
分类号 A61K31/09;A61K9/20;A61K9/48;A61K9/50;A61K31/485;A61K9/24 主分类号 A61K31/09
代理机构 代理人
主权项 1. A pharmaceutical composition comprising: a first portion; and a second portion; wherein the first portion comprises guaifenesin having an immediate release profile and a second drug having a sustained release profile; and wherein the second portion comprises guaifenesin having a sustained release profile.
地址 Parsippany NJ US